Eli Lilly stock to acquire Ventyx for $1.2 billion, Cantor Fitzgerald maintains Overweight rating
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
D-Wave Quantum stock rating reiterated at Overweight by Cantor Fitzgerald
Post Content
Initial jobless claims rise, but fall short of forecast
Post Content
BioVie completes enrollment for Parkinson’s drug trial
Post Content
Frontier Group names James G. Dempsey as president and CEO
Post Content
MannKind outlines 2026 growth drivers with key FDA decisions ahead
Post Content
Would you have invested in Berkshire Hathaway stock at the start of Warren Buffett’s career?
Buffett’s legendary investing record reveals a hard truth about the stock market.
FDA grants breakthrough therapy designation to Revolution Medicines’ lung cancer drug
Post Content
CorMedix reports $127 million Q4 revenue, provides 2026 outlook
Post Content
Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia
Post Content